Qc 1

Discontinued Product

5055 has been discontinued.

View all Other Dehydrogenases products.
说明: Metabolite
化学名: 1,2,3,4-Tetrahydro-4-oxo-N-(phenylmethyl)-2-thioxo-3-[3-(trifluoromethyl)phenyl]-7-quinazolinecarboxamide
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (2)

生物活性 for Qc 1

Qc 1 is a reversible, non-competitive inhibitor of threonine dehydrogenase (TDH) (IC50 ~500 nM). Induces autophagy and inhibits cell proliferation in mouse embryonic stem (ES) cells.

技术数据 for Qc 1

分子量 455.45
公式 C23H16F3N3O2S
储存 Store at +4°C
纯度 ≥98% (HPLC)
CAS Number 403718-45-6
PubChem ID 5000754
InChI Key IFNVTSPDMUUAFY-UHFFFAOYSA-N
Smiles O=C(N2C3=CC(C(F)(F)F)=CC=C3)C1=CC=C(C(NCC4=CC=CC=C4)=O)C=C1NC2=S

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

参考文献 for Qc 1

参考文献是支持产品生物活性的出版物。

Alexander et al (2011) Targeted killing of a mammalian cell based upon its specialized metabolic state. Proc.Natl.Acad.Sci.USA 108 15828 PMID: 21896756

按标靶查看相关产品

关键词: Qc 1, Qc 1 supplier, Qc1, threonine, dehydrogenase, inhibitors, inhibits, TDH, Other, Dehydrogenases, 5055, Tocris Bioscience

篇 Qc 1 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 Qc 1 的引用文献。

Qc 1 的评论

目前没有该产品的评论。 Be the first to review Qc 1 and earn rewards!

Have you used Qc 1?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Cancer Metabolism Research Product Guide

Cancer Metabolism Research Product Guide

This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including:

Cancer Metabolism Poster

Cancer Metabolism Poster

This poster summarizes the main metabolic pathways in cancer cells and highlights potential targets for cancer therapeutics. Genetic changes and epigenetic modifications in cancer cells alter the regulation of cellular metabolic pathways providing potential cancer therapeutic targets.